Siemens Healthineers AG (SMMNY) Stock

About Siemens Healthineers AG

Siemens Healthineers AG (SMMNY), operating through its various subsidiaries, is a global enterprise that provides a comprehensive suite of diagnostic and therapeutic medical products and services. These offerings are extended to healthcare professionals and institutions across numerous international markets, including Germany, the United States, the broader European continent, the CIS region, Africa, the Middle East, the Americas, the Asia Pacific region, Japan, and China. The company's business is structured across four primary divisions: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment supplies cutting-edge systems such as magnetic resonance imaging (MRI), computed tomography (CT), X-ray, molecular imaging, and ultrasound technologies. It also develops sophisticated software solutions designed to streamline the interpretation and structured reporting of diagnostic images from diverse modalities. The Diagnostics segment delivers in-vitro diagnostic products and associated services, catering to healthcare providers in both general and specialized laboratory settings, as well as point-of-care diagnostics. This division further offers workflow solutions to optimize laboratory operations and provides advanced informatics products. The Varian segment specializes in oncology solutions, featuring advanced technologies like microwave, cryoablation, and embolization. It also furnishes extensive clinical professional services and tailored support programs to assist oncology departments in hospitals and clinics with their cancer care operations. The Advanced Therapies segment focuses on developing products that facilitate image-guided, minimally invasive clinical procedures. These solutions are applied across various medical specialties, including cardiology, neurology, and oncology. Its portfolio includes angiography systems, mobile C-arms, and AI-powered clinical applications that enhance procedural precision. Beyond its core product lines, Siemens Healthineers AG offers a broad range of essential technical customer services. These include maintenance and repair, provision of spare parts, medical equipment performance management, training programs, clinical education, e-learning resources, planning and design assistance, financing options, asset management, and managed departmental services for laboratories and other healthcare facilities. The company also provides healthcare consulting, products, and additional services. Established in 1896, Siemens Healthineers AG maintains its corporate headquarters in Forchheim, Germany, and functions as a subsidiary of Siemens Aktiengesellschaft.

Siemens Healthineers AG is headquartered in DE.

Siemens Healthineers AG (SMMNY) stock trades at $21.95 with a market capitalization of $24.51B. The stock is valued at a price-to-earnings (P/E) ratio of 19.77, price-to-book of 2.29, price-to-sales of 1.89. Over the past 52 weeks the stock has ranged between $19.20 and $28.92, and currently trades 24.1% below its 52-week high. It pays a dividend yielding 2.69%.

On profitability, Siemens Healthineers AG generates a return on equity (ROE) of 12.00%, return on capital employed of 10.46%, an operating margin of 14.84%, a net profit margin of 9.55%.

In its most recent fiscal year, Siemens Healthineers AG reported annual revenue of $22.0B, net profit of $2.0B. Over the last 5 fiscal years, revenue grew at an average annual rate of 8.8%, and net profit grew at an average annual rate of 7.5%.

The balance sheet shows a debt-to-equity ratio of 0.79, a current ratio of 1.16, total assets of $52.1B, $2.2B in cash and equivalents.

SMMNY has an average daily trading volume of 96,666 shares, a beta of 0.83.

Official website: www.siemens-healthineers.com

Siemens Healthineers AG by the numbers, 2016–2025

Between 2016 and 2025 Siemens Healthineers AG reported revenue of $13.5B rising to $22.0B, a change of +62.6% across 10 years. Compounded, revenue has grown 8.8% a year over five years, 0.5% over three, -1.5% over the last twelve months. Net profit rose to $2.0B.

Operating margin went from 15.6% in 2016 to 14.7% in 2025, essentially unchanged. The most recent net margin is 9.55%. On a trailing twelve-month basis to Jun '26, revenue is $21.9B and net profit $2.2B.

Borrowings rose from $9.6B to $17.7B, cash on hand is $2.4B, cash from operations was $2.9B in the latest year, positive in 10 of the last 10.

Return on equity has averaged 9.9% over five years, and was 9.5% in the most recent year.

The share price itself has compounded at —% a year over five years, -3.7% over three, -21.4% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Siemens Healthineers AG (SMMNY) — frequently asked questions